Literature DB >> 475373

Comparison of a micromethod for performance of the serum bactericidal test with the standard tube dilution method.

C G Prober, S S Dougherty, K L Vosti, A S Yeager.   

Abstract

A micromethod for performance of the serum bactericidal test is described, and the results obtained with this method are compared with those obtained with the standard tube dilution macromethod. An agreement within +/- 1 dilution was achieved in 23 of 25 (92%) determinations of the serum bactericidal titer. The micromethod used approximately one-third of the amount of pooled normal human serum and of the technician's time required for performance of the macromethod. The micromethod offers an accurate and economical alternative to the macromethod for the performance of the serum bactericidal test and is particularly useful with infants and children since it minimizes blood loss.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475373      PMCID: PMC352786          DOI: 10.1128/AAC.16.1.46

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Combined antibiotic therapy in serious infections caused by drug-resistant staphylococci (1956-1957).

Authors:  E JAWETZ
Journal:  AMA Arch Intern Med       Date:  1959-02

2.  Comparison of broth and human serum as the diluent in the serum bactericidal test.

Authors:  F D Pien; R D Williams; K L Vosti
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

3.  Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.

Authors:  J Klastersky; D Daneau; G Swings; D Weerts
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Tube dilution antimicrobial susceptibility testing: efficacy of a microtechnique applicable to diagnostic laboratories.

Authors:  L A Chitwood
Journal:  Appl Microbiol       Date:  1969-05

5.  Variation in performance of the serum bactericidal test.

Authors:  F D Pien; K L Vosti
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

6.  Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent.

Authors:  C W Stratton; L B Reller
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

7.  Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis.

Authors:  T R Tetzlaff; G H McCracken; J D Nelson
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

  7 in total
  11 in total

Review 1.  Serum bactericidal test.

Authors:  C W Stratton
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.

Authors:  A Rodríguez; M V Vicente; T Olay
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 3.  Standardization of the serum bactericidal test and its relationship to levels of antimicrobial agents.

Authors:  C W Stratton
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

4.  LY146032 compared with penicillin G in experimental aortic valve endocarditis caused by group G streptococci.

Authors:  A S Bayer; J Yih; L Hirano
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

5.  MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.

Authors:  C J Shanholtzer; L R Peterson; M L Mohn; J A Moody; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers.

Authors:  O Petitjean; B Pangon; N Brion; M Tod; C Chaplain; V Le Gros; K Louchahi; P Allouch
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.

Authors:  A S Bayer; P Lindsay; J Yih; L Hirano; D Lee; I K Blomquist
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

8.  Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.

Authors:  A S Bayer; D Norman; K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

9.  Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.

Authors:  K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

Review 10.  Technical aspects and clinical correlations of the serum bactericidal test.

Authors:  H C Standiford; B A Tatem
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.